Analyst Reco. Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
5,010 ^JPY	+5.12%		+8.07%	+29.39%

Apr. 25	Scholz pledges further support for the pharmaceutical industry	DP
Apr. 25	Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy	Feb. 21	MT
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains	Feb. 20	MT
Japan's Nikkei slips after Fed chair signals delay in rate cut	Jan. 31	RE
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen	Dec. 04	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold	23-10-23	MT
Rising Interest Rates Lower Asian Stock Markets	23-10-19	MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen	23-09-25	MT
AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates	23-09-11	DJ
The Fed Opens Its Jackson Hole Conference With Interest Rate Path in Focus	23-08-24	DJ
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy	23-07-13	MT
AstraZeneca's Partner Daiichi Sankyo Says Enhertu Meets Objective Response Rate Target in Solid Tumors Phase 2 Trial	23-03-06	MT
Astrazeneca and Daiichi Sankyo's Enhertu Met Prespecified Criteria for Objective Response Rate and Duration of Response	23-03-06	CI
Japan's Nikkei ends at 1-month low amid political, rate-hike worries	23-02-22	RE
Nikkei drops to 1-month low on political tensions, rate-hike worries	23-02-21	RE
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy	22-12-14	MT
Nikkei little changed, pinned down by rates worry	22-11-20	RE
Japan's Nikkei snaps 5-day losing streak amid US rate caution	22-08-25	RE
MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022	22-06-06
FTSE Flat, PMI Data Adds to Case for Another BoE Rate Increase	22-02-21	DJ
AstraZeneca-Daiichi Sankyo's Enhertu Improves Progression-Free Survival, Objective Response Rate in Brain Metastases Patients	21-12-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Analyst Reco.

Filters